Payer Strategy

Payer strategy coverage this week centered on affordability pressure and trust erosion, with payers defending insurance’s role in shielding members from catastrophic costs while critics argued the problem is structural—benefit design, pricing opacity, and cost-shifting are undermining perceived value, especially among younger commercially insured members. For VBC stakeholders, the signal is that payer-provider partnerships will need to move beyond total-cost-of-care rhetoric toward visible member-level affordability outcomes, including lower out-of-pocket exposure, medication access, and transparent care navigation, as reflected in debates over structural affordability solutions and AHIP’s defense of insurance protection against high medical costs. The most actionable delivery-model thread was pharmacy-based care: collaborative drug therapy management pharmacists are positioning medication optimization, adherence improvement, and chronic disease support as measurable payer value—an opportunity for ACOs and risk-bearing groups to integrate pharmacists more tightly into population health workflows.